Showing results (121-130 of 719) with videos related to

Sort By:
Pageof 72
Australasian Radiology|July 3, 2004
Transverse sinus septum: a new aetiology of idiopathic intracranial hypertension?Rathan M Subramaniam, Brian M Tress, John O King, et al.
Nuclear Medicine Communications|December 12, 2017
Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platformsJoyce C Mhlanga, Alin Chirindel, Martin A Lodge, et al.
PET Clinics|November 20, 2016
Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in OncologySara Sheikhbahaei, Esther Mena, Puskar Pattanayak, et al.
Nuclear Medicine Communications|July 6, 2017
Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancerSara Sheikhbahaei, Se J Ahn, Brenda Young, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2014
Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer PatientsAlexander J Antoniou, Charles Marcus, Abdel K Tahari, et al.
AJR. American Journal of Roentgenology|October 27, 2015
Intratherapy or Posttherapy FDG PET or FDG PET/CT for Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis of Prognostic StudiesSara Sheikhbahaei, Se Jin Ahn, Elizabeth Moriarty, et al.
Nuclear Medicine Communications|February 24, 2023
Utility of pre-treatment 18 F-fluorodeoxyglucose PET radiomic analysis in assessing nodal involvement in cervical cancerKit Chi Chan, Jose A U Perucho, Rathan M Subramaniam, et al.
AJR. American Journal of Roentgenology|April 25, 2014
FDG PET metabolic tumor volume segmentation and pathologic volume of primary human solid tumorsPraveen Sridhar, Gustavo Mercier, Josenia Tan, et al.
Skeletal Radiology|May 8, 2013
Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imagingShivani Ahlawat, Jaishri Blakeley, Elizabeth Montgomery, et al.
Pageof 72